ERα/LKB1 complex upregulates E‐cadherin expression and stimulates breast cancer growth and progression upon adiponectin exposure
Authors:
Open Access
- 16 June 2023
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 153 (6) , 1257-1272
Abstract
Adiponectin is the major adipocytes‐secreted protein involved in obesity‐related breast cancer growth and progression. We proved that adiponectin promotes proliferation in ERα‐positive breast cancer cells, through ERα transactivation and the recruitment of LKB1 as ERα‐coactivator. Here, we showed that adiponectin‐mediated ERα transactivation enhances E‐cadherin expression. Thus, we investigated the molecular mechanism through which ERα/LKB1 complex may modulate the expression of E‐cadherin, influencing tumor growth, progression and distant metastasis. We demonstrated that adiponectin increases E‐cadherin expression in ERα‐positive 2D and higher extent in 3D cultures. This occurs through a direct activation of E‐cadherin gene promoter by ERα/LKB1‐complex. The impact of E‐cadherin on ERα‐positive breast cancer cell proliferation comes from the evidence that in the presence of E‐cadherin siRNA the proliferative effects of adiponectin is no longer noticeable. Since E‐cadherin connects cell polarity and growth, we investigated if the adiponectin‐enhanced E‐cadherin expression could influence the localization of proteins cooperating in cell polarity, such as LKB1 and Cdc42. Surprisingly, immunofluorescence showed that, in adiponectin‐treated MCF‐7 cells, LKB1 and Cdc42 mostly colocalize in the nucleus, impairing their cytosolic cooperation in maintaining cell polarity. The orthotopic implantation of MCF‐7 cells revealed an enhanced E‐cadherin‐mediated breast cancer growth induced by adiponectin. Moreover, tail vein injection of MCF‐7 cells showed a higher metastatic burden in the lungs of mice receiving adiponectin‐treated cells compared to control. From these findings it emerges that adiponectin treatment enhances E‐cadherin expression, alters cell polarity and stimulates ERα‐positive breast cancer cell growth in vitro and in vivo, sustaining higher distant metastatic burden.Keywords
This publication has 50 references indexed in Scilit:
- Comprehensive molecular portraits of human breast tumoursNature, 2012
- LKB1 and AMP‐activated protein kinase: regulators of cell polarityGenes to Cells, 2012
- Resveratrol, through NF‐Y/p53/Sin3/HDAC1 complex phosphorylation, inhibits estrogen receptor α gene expression via p38 MAPK /CK2 signaling in human breast cancer cellsThe FASEB Journal, 2011
- Liver Kinase B1 (LKB1) in the pathogenesis of epithelial cancersCancer Letters, 2011
- Breast carcinoma cells re-express E-cadherin during mesenchymal to epithelial reverting transitionMolecular Cancer, 2010
- Akt2 Inhibition Enables the Forkhead Transcription Factor FoxO3a To Have a Repressive Role in Estrogen Receptor α Transcriptional Activity in Breast Cancer CellsMolecular and Cellular Biology, 2010
- LKB1 Catalytic Activity Contributes to Estrogen Receptor α SignalingMolecular Biology of the Cell, 2009
- ERα as ligand-independent activator of CDH-1 regulates determination and maintenance of epithelial morphology in breast cancer cellsProceedings of the National Academy of Sciences, 2009
- Regulation of LKB1/STRAD Localization and Function by E-CadherinCurrent Biology, 2009
- The Tumor Suppressor LKB1 Regulates Lung Cancer Cell Polarity by Mediating cdc42 Recruitment and ActivityCancer Research, 2008